The Library
Stakeholder experiences of deprescribing psychotropic medicines for challenging behaviour in people with intellectual disabilities
Tools
Adams, Danielle, Hastings, Richard P., Maidment, Ian, Shah, Chetan and Langdon, Peter E. (2024) Stakeholder experiences of deprescribing psychotropic medicines for challenging behaviour in people with intellectual disabilities. Tizard Learning Disability Review . doi:10.1108/TLDR-09-2023-0020 ISSN 1359-5474. (In Press)
|
PDF
WRAP-Stakeholder-experiences-deprescribing-psychotropic-medicines-24.pdf - Accepted Version - Requires a PDF viewer. Download (432Kb) | Preview |
Official URL: http://doi.org/10.1108/TLDR-09-2023-0020
Abstract
Purpose
Evidence of overprescribing of psychotropic medicines to manage challenging behaviour in people with intellectual disabilities has led to national programmes within the UK to promote deprescribing, such as stopping the overprescribing of medication in people (with learning disabilities, autism or both). To successfully implement deprescribing initiatives, we need to understand how to engage stakeholders in the process.
Design/methodology/approach
In a published systematic review, we reported evidence about the process of deprescribing psychotropic medicines for people of all ages with intellectual disabilities and challenging behaviour. As a part of the original review, we searched for evidence about stakeholders’ experiences of the psychotropic deprescribing process, which was synthesised and reported within the current study.
Findings
Six studies were identified. Involving carers and people with intellectual disabilities, providing ongoing support and improving access to non-pharmacological interventions, including positive behaviour support, may contribute to successful outcomes, including reducing or stopping psychotropic medicines and improving quality of life. Implementing psychotropic deprescribing requires a multidisciplinary collaborative care approach and education for stakeholders.
Originality/value
There have been no previous reviews of stakeholder experiences of deprescribing psychotropic medications for people with intellectual disabilities and challenging behaviour. The existing literature is scant, and further research is needed.
Item Type: | Journal Article | ||||||
---|---|---|---|---|---|---|---|
Subjects: | H Social Sciences > HV Social pathology. Social and public welfare R Medicine > RA Public aspects of medicine R Medicine > RC Internal medicine R Medicine > RM Therapeutics. Pharmacology |
||||||
Divisions: | Faculty of Social Sciences > Centre for Educational Development, Appraisal and Research (CEDAR) | ||||||
Library of Congress Subject Headings (LCSH): | Psychotropic drugs -- Supply and demand, Drugs -- Prescribing, People with mental disabilities , People with mental disabilities -- Care, Intellectual disability, People with mental disabilities -- Behavior modification | ||||||
Journal or Publication Title: | Tizard Learning Disability Review | ||||||
Publisher: | Emerald Group Publishing Ltd. | ||||||
ISSN: | 1359-5474 | ||||||
Official Date: | 30 January 2024 | ||||||
Dates: |
|
||||||
DOI: | 10.1108/TLDR-09-2023-0020 | ||||||
Status: | Peer Reviewed | ||||||
Publication Status: | In Press | ||||||
Access rights to Published version: | Restricted or Subscription Access | ||||||
Copyright Holders: | Copyright © 2024, Emerald Publishing Limited | ||||||
Date of first compliant deposit: | 6 February 2024 | ||||||
Date of first compliant Open Access: | 7 February 2024 |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |
Downloads
Downloads per month over past year